Abou Dalle, I., & DiNardo, C. D. (2018). The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia. Ther Adv Hematol.
Citação norma ChicagoAbou Dalle, Iman, and Courtney D. DiNardo. "The Role of Enasidenib in the Treatment of Mutant IDH2 Acute Myeloid Leukemia." Ther Adv Hematol 2018.
MLA CitationAbou Dalle, Iman, and Courtney D. DiNardo. "The Role of Enasidenib in the Treatment of Mutant IDH2 Acute Myeloid Leukemia." Ther Adv Hematol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.